Compares treatment options for The Time Taken for Successful Tracheal Intubation in Each...
Official title Orotracheal Intubation in Newborns: Videolaryngoscopy Vs Direct Laryngoscopy
ClinicalTrials.gov ID: NCT06655168
What this study is testing
- What it's testing
- The children were randomized into two groups to receive orotracheal intubation after anesthetic induction with neuromuscular blockade, either by direct laryngoscopy (DL, DL group) or by C-MAC video laryngoscopy (VL group)
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 30
You may be able to join if
- newborns requiring orotracheal intubation for surgery or mechanical ventilation in the intensive care unit
You likely can't join if
- age\> 01 month
The study team makes the final eligibility decision.
Where it's taking place
- Tunis, Tunis Governorate, Tunisia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 minute to 30 days. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tunis, Tunis Governorate, Tunisia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.